We assess your health history and individual needs before starting the therapy to ensure the treatment is right for you
As GLP-1 receptor agonists (GLP-1s) like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro, Zepbound) become increasingly common in the treatment of diabetes, obesity, and cardiovascular disease, retina specialists are paying close attention to whether the drug therapies may influence ocular disease in already high-risk patients
By staying informed and adaptable, breweries can navigate these changes and continue to thrive in a shifting market landscape
Hello Dr
GLP-1 medications are FDA-approved for specific indications, and eligibility is determined by a licensed clinician
Pastorello E, Stocchi L, Bigi A, Pravettoni V, Schilke ML, Valente D, & Zanussi C (1989) Value and limits of diagnostic tests in food hypersensitivity